However, the mRNA levels of SREBP-1c were notably elevated in hepatic ChREBP knockout mice compared to WT mice, indicating that SREBP-1c expression was likely a compensatory response to the absence of ChREBP for hepatic steatosis and contributed in the NAFLD development in our study. This evidence concerns the gene MLXIPL and fatty liver disease.